4//SEC Filing
Salzman Amber 4
Accession 0001209191-20-054609
CIK 0001662524other
Filed
Oct 12, 8:00 PM ET
Accepted
Oct 13, 3:39 PM ET
Size
8.1 KB
Accession
0001209191-20-054609
Insider Transaction Report
Form 4
Salzman Amber
Director
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2020-10-12$0.21/sh−53,000$11,130→ 0 totalExercise: $17.94Exp: 2030-02-11→ Common Stock (53,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2020-10-12$2.01/sh−26,400$53,064→ 0 totalExercise: $16.14Exp: 2030-04-12→ Common Stock (26,400 underlying)
Footnotes (2)
- [F1]This option, which provided for vesting of the shares over a four year period in equal annual installments beginning on February 12, 2020, was cancelled in connection with the merger of the Issuer with a wholly owned subsidiary of Ionis Pharmaceuticals, Inc. in exchange for a cash payment of $11,130.00, representing the difference between the exercise price of the option and the acquisition price of $18.15.
- [F2]This option, which provided for vesting of the shares on April 13, 2021, was cancelled in connection with the merger of the Issuer with a wholly owned subsidiary of Ionis Pharmaceuticals, Inc. in exchange for a cash payment of $53,064.00, representing the difference between the exercise price of the option and the acquisition price of $18.15.
Documents
Issuer
AKCEA THERAPEUTICS, INC.
CIK 0001662524
Entity typeother
Related Parties
1- filerCIK 0001674536
Filing Metadata
- Form type
- 4
- Filed
- Oct 12, 8:00 PM ET
- Accepted
- Oct 13, 3:39 PM ET
- Size
- 8.1 KB